Literature DB >> 6098684

Breakage of single-stranded DNA by eukaryotic type 1 topoisomerase occurs only at regions with the potential for base-pairing.

M D Been, J J Champoux.   

Abstract

Eukaryotic type 1 DNA topoisomerases break single-stranded DNA at specific sites. A preferred site for rat liver topoisomerase breakage in single-stranded phi X174 DNA was located within a region of the DNA with the potential for duplex formation. To investigate the relationship between sites of breakage in duplex and single-stranded DNA, a restriction fragment containing sequences from the transcriptional regulatory and enhancer region of the simian virus 40 genome was used as a substrate for topoisomerase. While different patterns of breakage in the native and denatured forms of the DNA were observed, some sites of breakage were common to both forms. The break sites in the denatured DNA were a subset of the break sites in the duplex DNA and were located in regions which had the potential for intrastrand base-pairing due to distal complementary sequences. A series of single-stranded fragments were generated with the distal complementary sequences deleted and these fragments were used as substrates for topoisomerase breakage. The lack of detectable breakage at a site when the complementary sequence was deleted, suggests that topoisomerase acts at duplex regions in the single-stranded DNA and that it is not active on regions of single-stranded DNA that are not base-paired.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6098684     DOI: 10.1016/0022-2836(84)90025-1

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  12 in total

1.  Expression of yeast DNA topoisomerase I can complement a conditional-lethal DNA topoisomerase I mutation in Escherichia coli.

Authors:  M A Bjornsti; J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  Inhibition of HeLa cell DNA topoisomerase I by ATP and phosphate.

Authors:  R L Low; J A Holden
Journal:  Nucleic Acids Res       Date:  1985-10-11       Impact factor: 16.971

3.  Pausing sites of RNA polymerase II on actively transcribed genes are enriched in DNA double-stranded breaks.

Authors:  Sandeep Singh; Karol Szlachta; Arkadi Manukyan; Heather M Raimer; Manikarna Dinda; Stefan Bekiranov; Yuh-Hwa Wang
Journal:  J Biol Chem       Date:  2020-02-06       Impact factor: 5.157

4.  Illegitimate recombination at the replication origin of bacteriophage M13.

Authors:  B Michel; S D Ehrlich
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

5.  Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.

Authors:  C Jaxel; K W Kohn; Y Pommier
Journal:  Nucleic Acids Res       Date:  1988-12-09       Impact factor: 16.971

Review 6.  The Top1 paradox: Friend and foe of the eukaryotic genome.

Authors:  Nayun Kim; Sue Jinks-Robertson
Journal:  DNA Repair (Amst)       Date:  2017-06-09

7.  Molecular docking approach on the Topoisomerase I inhibitors series included in the NCI anti-cancer agents mechanism database.

Authors:  Antonino Lauria; Mario Ippolito; Anna Maria Almerico
Journal:  J Mol Model       Date:  2006-10-28       Impact factor: 1.810

8.  Transfection and homologous recombination involving single-stranded DNA substrates in mammalian cells and nuclear extracts.

Authors:  S Rauth; K Y Song; D Ayares; L Wallace; P D Moore; R Kucherlapati
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

9.  Topoisomerase 1-dependent deletions initiated by incision at ribonucleotides are biased to the non-transcribed strand of a highly activated reporter.

Authors:  Jang-Eun Cho; Nayun Kim; Sue Jinks-Robertson
Journal:  Nucleic Acids Res       Date:  2015-08-13       Impact factor: 16.971

10.  DNA secondary structure at chromosomal fragile sites in human disease.

Authors:  Ryan G Thys; Christine E Lehman; Levi C T Pierce; Yuh-Hwa Wang
Journal:  Curr Genomics       Date:  2015-02       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.